Home Tags Zanidatamab

Tag: Zanidatamab

Golden Gate Bridge view at foggy morning, San Francisco, California,

Combination of Zanidatamab + Chemotherapy may Slow Cancer Growth and Extend...

Peter Hofland -

ESMO 2023: Novel Treatment Options Demonstrate a Growing Impact in Solid...

Peter Hofland -

Potential Chemotherapy-free option in HER2+/HR+ mBC with Zanidatamab + Palbociclib +...

Editorial Team -

Jazz Pharmaceuticals and Zymeworks Agree to Jointly Develop and Commercialize Zanidatamab

Danielle Garcia -

Promising Activity with Zanidatamab In First-line Setting Of HER2+ Breast +...

Danielle Garcia -

Zanidatamab Shows Encouraging Antitumor Activity in Heavily Pretreated HER2-Positive Breast Cancer

Editorial Team -

Phase 3 Zanidatamab Study in First-Line HER2+ Gastroesophageal Adenocarcinoma Enrolls Patients

Peter Hofland -
Zymeworks' detailed understanding of protein dynamics helps the company's research scientists to profile protein hotspots and refine protein engineering approaches. Photo Courtesy Zymeworks.

Zanidatamab Shows Promising Response in First-Line HER2-Positive Gastroesophageal Adenocarcinoma

Editorial Team -

LATEST NEWS